Superoxide dismutase 1 (SOD1, 2%) and Fused in Sarcoma (FUS, <1%) pathologies are involved in the rest of ALS cases while TAU (45%) and FUS (9%) pathologies makes up the remaining FTD pathologies (Ling et al., 2013). The gene discussed is SOD1; the disease is frontotemporal dementia.